| pubmed-article:19209016 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19209016 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:19209016 | lifeskim:mentions | umls-concept:C0017185 | lld:lifeskim |
| pubmed-article:19209016 | lifeskim:mentions | umls-concept:C0027498 | lld:lifeskim |
| pubmed-article:19209016 | lifeskim:mentions | umls-concept:C1176306 | lld:lifeskim |
| pubmed-article:19209016 | lifeskim:mentions | umls-concept:C0199176 | lld:lifeskim |
| pubmed-article:19209016 | lifeskim:mentions | umls-concept:C0175668 | lld:lifeskim |
| pubmed-article:19209016 | pubmed:issue | 1-2 | lld:pubmed |
| pubmed-article:19209016 | pubmed:dateCreated | 2009-2-11 | lld:pubmed |
| pubmed-article:19209016 | pubmed:abstractText | Chemotherapy-induced nausea and vomiting (CINV) belongs to the most feared side-effects of cancer treatment. Its incidence during chemotherapy of gastrointestinal tumors (GITs) with highly and moderately emetogenic regimens is not well documented. It is also unknown whether aprepitant, a neurokinin-1 receptor antagonist, can be used as secondary antiemetic prophylaxis in case of CINV during cycle 1. | lld:pubmed |
| pubmed-article:19209016 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19209016 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19209016 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19209016 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19209016 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19209016 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19209016 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19209016 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:19209016 | pubmed:issn | 1423-0240 | lld:pubmed |
| pubmed-article:19209016 | pubmed:author | pubmed-author:PeschelChrist... | lld:pubmed |
| pubmed-article:19209016 | pubmed:author | pubmed-author:LordickFloria... | lld:pubmed |
| pubmed-article:19209016 | pubmed:author | pubmed-author:Ihbe-Heffinge... | lld:pubmed |
| pubmed-article:19209016 | pubmed:author | pubmed-author:AbbrederisKat... | lld:pubmed |
| pubmed-article:19209016 | pubmed:author | pubmed-author:SchusterTibor... | lld:pubmed |
| pubmed-article:19209016 | pubmed:author | pubmed-author:LorenzenSylvi... | lld:pubmed |
| pubmed-article:19209016 | pubmed:author | pubmed-author:RothlingNadin... | lld:pubmed |
| pubmed-article:19209016 | pubmed:copyrightInfo | Copyright (c) 2009 S. Karger AG, Basel. | lld:pubmed |
| pubmed-article:19209016 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19209016 | pubmed:volume | 32 | lld:pubmed |
| pubmed-article:19209016 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19209016 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19209016 | pubmed:pagination | 30-4 | lld:pubmed |
| pubmed-article:19209016 | pubmed:meshHeading | pubmed-meshheading:19209016... | lld:pubmed |
| pubmed-article:19209016 | pubmed:meshHeading | pubmed-meshheading:19209016... | lld:pubmed |
| pubmed-article:19209016 | pubmed:meshHeading | pubmed-meshheading:19209016... | lld:pubmed |
| pubmed-article:19209016 | pubmed:meshHeading | pubmed-meshheading:19209016... | lld:pubmed |
| pubmed-article:19209016 | pubmed:meshHeading | pubmed-meshheading:19209016... | lld:pubmed |
| pubmed-article:19209016 | pubmed:meshHeading | pubmed-meshheading:19209016... | lld:pubmed |
| pubmed-article:19209016 | pubmed:meshHeading | pubmed-meshheading:19209016... | lld:pubmed |
| pubmed-article:19209016 | pubmed:meshHeading | pubmed-meshheading:19209016... | lld:pubmed |
| pubmed-article:19209016 | pubmed:meshHeading | pubmed-meshheading:19209016... | lld:pubmed |
| pubmed-article:19209016 | pubmed:meshHeading | pubmed-meshheading:19209016... | lld:pubmed |
| pubmed-article:19209016 | pubmed:meshHeading | pubmed-meshheading:19209016... | lld:pubmed |
| pubmed-article:19209016 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19209016 | pubmed:articleTitle | Chemotherapy-induced nausea and vomiting in the treatment of gastrointestinal tumors and secondary prophylaxis with aprepitant. | lld:pubmed |
| pubmed-article:19209016 | pubmed:affiliation | 3. Medizinische Klinik (Hamatologie/Onkologie), Munich, Germany. | lld:pubmed |
| pubmed-article:19209016 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19209016 | pubmed:publicationType | Controlled Clinical Trial | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19209016 | lld:pubmed |
